The Plight of the Whistleblower

Joelle BoltAfter garnering data on the harmful effects of dust from sewage sludge used as fertilizer on US and Canadian farms, David Lewis, former microbiologist with the Environmental Protection Agency (EPA), spoke out in Nature articles.12 The ensuing confrontation with his superiors would get him terminated from the EPA. "I never thought of myself as a whistleblower," he says. To Lewis, whistleblowers pointed fingers at people who fraudulently spent government money to buy things like private

Written byEugene Russo
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Joelle Bolt

After garnering data on the harmful effects of dust from sewage sludge used as fertilizer on US and Canadian farms, David Lewis, former microbiologist with the Environmental Protection Agency (EPA), spoke out in Nature articles.12 The ensuing confrontation with his superiors would get him terminated from the EPA. "I never thought of myself as a whistleblower," he says. To Lewis, whistleblowers pointed fingers at people who fraudulently spent government money to buy things like private boats.

Lewis says he was willing to lose his job, but initially he didn't think that would happen. He was confident that the data would stand on its own merit once published. But Lewis would soon conclude that the protections for federal employees are less than adequate. After termination, he continued his work at the University of Georgia while he pleaded his case. But following further investigations into his research by opposing attorneys, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies